Arcus Biosciences, Inc (RCUS) insider trading
Every open-market stock purchase and sale by Arcus Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Juan C. Jaen (President) and 1 other sold $2.1M in the last 90 days.
- Last insider buy: Terry J Rosen (CEO), $201K, 19 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $14.4M (23 sales). Last close $30.76 on Aug 26, 2026.
Recent RCUS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 21, 2026 | Alexander Azoy (C-suite exec) | Sold | $84.8K |
| Aug 21, 2026 | Alexander Azoy (C-suite exec) | Bought (not open market) | — |
| Jul 10, 2026 | Juan C. Jaen (President) | Sold | $566K |
| Jul 10, 2026 | Juan C. Jaen (President) | Sold | $7.9K |
| Jul 9, 2026 | Juan C. Jaen (President) | Sold | $1.5M |
| Jun 24, 2026 | Juan C. Jaen (President) | Sold | $191K |
| Jun 23, 2026 | Juan C. Jaen (President) | Sold | $389K |
| Jun 23, 2026 | Juan C. Jaen (President) | Sold | $47.6K |
| Jun 22, 2026 | Juan C. Jaen (President) | Sold | $250K |
| Jun 11, 2026 | Carolyn C. Tang (General Counsel) | Bought (not open market) | $87.7K |
| Jun 11, 2026 | Nicole Lambert (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Nicole Lambert (Director) | Bought (not open market) | — |
| Jun 11, 2026 | David L. Lacey (Director) | Bought (not open market) | — |
| Jun 11, 2026 | David L. Lacey (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Patrick Machado (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Patrick Machado (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Yasunori Kaneko (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Yasunori Kaneko (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Kathryn E Falberg (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Kathryn E Falberg (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Andrew J Perlman (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Andrew J Perlman (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Antoni Ribas (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Antoni Ribas (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Alexander Azoy (C-suite exec) | Sold | $66K |
Who's trading RCUS
- Alexander Azoy, C-suite exec: sold $396K (6 sales), last Aug 21, 2026
- Juan C. Jaen, President: sold $9.2M (21 sales), last Jul 10, 2026
- Carolyn C. Tang, General Counsel: sold $318K (2 sales), last Jun 11, 2026
- Kathryn E Falberg, Director: other filings, last Jun 11, 2026
- Yasunori Kaneko, Director: other filings, last Jun 11, 2026
- David L. Lacey, Director: other filings, last Jun 11, 2026
- Nicole Lambert, Director: other filings, last Jun 11, 2026
- Patrick Machado, Director: other filings, last Jun 11, 2026
- Andrew J Perlman, Director: other filings, last Jun 11, 2026
- Antoni Ribas, Director: other filings, last Jun 11, 2026
- Robert C. Goeltz II, CFO: sold $856K (6 sales), last May 11, 2026
- Jennifer Jarrett, COO: sold $2.2M (5 sales), last Jan 23, 2026
- Richard Markus, C-suite exec: sold $210K (2 sales), last Jan 23, 2026
- Terry J Rosen, CEO: sold $1.2M (2 sales), last Jan 23, 2026
Get free alerts when an insider at Arcus Biosciences, Inc files a new trade →